Core Viewpoint - Costco Wholesale is facing a proposed class action lawsuit regarding undisclosed salmonella risks associated with its rotisserie chicken sold at a Nebraska processing plant [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Costco's chicken processing facility in Fremont consistently fails to meet USDA safety standards, with testing data showing over 9.8% of whole chickens and 15.4% of chicken parts testing positive for Salmonella [2]. - The complaint seeks compensatory and triple damages for consumers who purchased Kirkland Signature rotisserie chicken and raw chicken parts from January 1, 2019, onward, alleging breaches of Washington consumer protection laws [3]. Group 2: Sales and Financial Performance - Costco's rotisserie chicken is priced at $4.99, recognized as a loss leader to attract customers, with global sales exceeding 157 million units in 2025 [2]. - In the first quarter of fiscal 2026, Costco reported net sales of $65.98 billion, an increase of 8.2% from $60.99 billion the previous year [4].

Core Viewpoint - Becton, Dickinson and Company (BDX) has issued an urgent update regarding its esophagogastric balloon tamponade tubes due to safety concerns following one reported death and two serious injuries related to the device's use [1][2][4]. Company Update - The FDA has highlighted BD's updated instructions for the device, emphasizing potential hazards and the importance of proper usage procedures [2][6]. - BD has a market capitalization of $49.59 billion and an earnings yield of 8.1%, which is higher than the industry average of 5.3% [5]. Stock Performance - Following the announcement, BDX shares traded flat until Thursday's closing, with a year-to-date decline of 23.4%, compared to the industry's 0.8% decline and the S&P 500's 0.3% loss [3]. Safety Concerns - The FDA's safety communication was prompted by issues with the device during the pre-use phase, particularly difficulties in removing plastic plugs, which could damage the device [6][8]. - Complications from these issues could delay diagnosis or treatment, potentially worsening patient outcomes [8]. Response Measures - In response to the incidents, BD has communicated revised preparation steps to customers, including specific methods for safely removing plugs from the device [9][10]. - BD is reinforcing training across healthcare facilities and reviewing product handling instructions to enhance patient safety [10].